Flexible Stenting Solutions Overview

  • Year Founded
  • 2006

Year Founded

  • Status
  • Acquired/​Merged

  • Latest Deal Type
  • M&A

Flexible Stenting Solutions General Information

Description

Developer of third-generation flexible peripheral arterial and biliary stents. The company develops stents on a proprietary design platform.

Contact Information

Ownership Status
Acquired/Merged
Financing Status
Formerly VC-backed
Corporate Office
  • 23 Christopher Way
  • Suite 103
  • Eatontown, NJ 07724
  • United States
+1 (732)
Primary Industry
Surgical Devices
Other Industries
Biotechnology
Acquirer
Corporate Office
  • 23 Christopher Way
  • Suite 103
  • Eatontown, NJ 07724
  • United States
+1 (732)

Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Flexible Stenting Solutions Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
6. Merger/Acquisition 12-Mar-2013 Completed Generating Revenue
5. Buyout/LBO 03-Jan-2012 Completed Profitable
4. Early Stage VC (Series B) 06-May-2011 Completed Generating Revenue
3. Early Stage VC 11-Nov-2010 Completed Product Development
2. Early Stage VC 24-Aug-2009 Completed Product Development
1. Early Stage VC (Series A) 18-Jan-2008 Completed Product Development
To view Flexible Stenting Solutions’s complete valuation and funding history, request access »

Flexible Stenting Solutions Patents

Flexible Stenting Solutions Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
US-20160120677-A1 Method and system for controlled stent deployment and reconstraint Inactive 03-Nov-2014
ES-2706992-T3 Stent delivery system that can be constrained again Active 13-Jun-2011
CA-2841542-A1 Reconstrainable stent delivery system Active 13-Jun-2011
US-20120310321-A1 Reconstrainable stent delivery system Inactive 13-Jun-2011
CA-2841542-C Reconstrainable stent delivery system Active 13-Jun-2011 A61F2/91
To view Flexible Stenting Solutions’s complete patent history, request access »

Flexible Stenting Solutions Former Investors (4)

Investor Name Investor Type Holding Investor Since Participating Rounds
Biomark Capital PE/Buyout Minority
Burrill & Co Merchant Banking Firm Minority
Goodman Company Corporation Minority
SNL Partners Venture Capital Minority
To view Flexible Stenting Solutions’s complete investors history, request access »

Flexible Stenting Solutions FAQs

  • When was Flexible Stenting Solutions founded?

    Flexible Stenting Solutions was founded in 2006.

  • Where is Flexible Stenting Solutions headquartered?

    Flexible Stenting Solutions is headquartered in Eatontown, NJ.

  • What industry is Flexible Stenting Solutions in?

    Flexible Stenting Solutions’s primary industry is Surgical Devices.

  • Is Flexible Stenting Solutions a private or public company?

    Flexible Stenting Solutions is a Private company.

  • What is Flexible Stenting Solutions’s current revenue?

    The current revenue for Flexible Stenting Solutions is .

  • Who are Flexible Stenting Solutions’s investors?

    Biomark Capital, Burrill & Co, Goodman Company, and SNL Partners have invested in Flexible Stenting Solutions.

  • When was Flexible Stenting Solutions acquired?

    Flexible Stenting Solutions was acquired on 12-Mar-2013.

  • Who acquired Flexible Stenting Solutions?

    Flexible Stenting Solutions was acquired by Cordis.

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read blog »
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process »